ALNYLAM PHARMACEUTICALS, INC. Insider Trading for November 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALNYLAM PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALNYLAM PHARMACEUTICALS, INC. for November 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 24 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 31.39 | 73,415 | 2,304,497 | 0 | |
| Nov 24 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 132.73 | 2,683 | 356,115 | 149,710 | 152.4 K to 149.7 K (-1.76 %) |
| Nov 24 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 131.82 | 20,433 | 2,693,478 | 152,393 | 172.8 K to 152.4 K (-11.82 %) |
| Nov 24 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 130.88 | 25,036 | 3,276,712 | 172,826 | 197.9 K to 172.8 K (-12.65 %) |
| Nov 24 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 129.97 | 25,263 | 3,283,432 | 197,862 | 223.1 K to 197.9 K (-11.32 %) |
| Nov 24 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 31.39 | 73,415 | 2,304,497 | 223,125 | 149.7 K to 223.1 K (+49.04 %) |
| Nov 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 31.39 | 74,000 | 2,322,860 | 73,415 | |
| Nov 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 130.22 | 600 | 78,131 | 149,710 | 150.3 K to 149.7 K (-0.40 %) |
| Nov 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 129.57 | 4,850 | 628,415 | 150,310 | 155.2 K to 150.3 K (-3.13 %) |
| Nov 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 128.48 | 10,571 | 1,358,204 | 155,160 | 165.7 K to 155.2 K (-6.38 %) |
| Nov 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 127.54 | 7,120 | 908,085 | 165,731 | 172.9 K to 165.7 K (-4.12 %) |
| Nov 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 126.60 | 28,399 | 3,595,399 | 172,851 | 201.3 K to 172.9 K (-14.11 %) |
| Nov 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 125.54 | 22,460 | 2,819,718 | 201,250 | 223.7 K to 201.3 K (-10.04 %) |
| Nov 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 31.39 | 74,000 | 2,322,860 | 223,710 | 149.7 K to 223.7 K (+49.43 %) |
| Nov 08 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | A | 88.95 | 7,500 | 667,125 | 7,500 | |
| Nov 08 2017 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | A | 88.95 | 1,800 | 160,110 | 1,800 | |
| Nov 08 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 88.95 | 16,250 | 1,445,438 | 16,250 | |
| Nov 08 2017 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Option Exercise | A | 88.95 | 3,500 | 311,325 | 3,500 | |
| Nov 08 2017 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | A | 88.95 | 10,000 | 889,500 | 10,000 | |
| Nov 03 2017 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Option Exercise | M | 30.09 | 20,000 | 601,800 | 0 | |
| Nov 03 2017 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Sell | S | 130.00 | 20,000 | 2,600,000 | 0 | 20 K to 0 (-100.00 %) |
| Nov 03 2017 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Buy | M | 30.09 | 20,000 | 601,800 | 20,000 | 0 to 20 K |
| Nov 01 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | M | 21.35 | 33,666 | 718,769 | 0 | |
| Nov 01 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Sell | S | 122.79 | 3,693 | 453,463 | 11,535 | 15.2 K to 11.5 K (-24.25 %) |
| Nov 01 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Sell | S | 121.69 | 17,755 | 2,160,606 | 15,228 | 33 K to 15.2 K (-53.83 %) |
| Nov 01 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Sell | S | 120.78 | 11,418 | 1,379,066 | 32,983 | 44.4 K to 33 K (-25.72 %) |
| Nov 01 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Sell | S | 119.79 | 800 | 95,832 | 44,401 | 45.2 K to 44.4 K (-1.77 %) |
| Nov 01 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Buy | M | 21.35 | 33,666 | 718,769 | 45,201 | 11.5 K to 45.2 K (+291.86 %) |